妇女健康研究进展与机遇

与当代生物医学及行为研究的某些挑战比较，近年来，妇女健康研究概念的延伸和扩展是平行甚至超前的。15年前，妇女健康研究主要集中在生殖健康方面。尽管女性并非总被排除于生殖系统之外的临床研究，但是在同时涉及女性和男性的临床试验并未常规确定女性与男性的差别。为了拓宽女性健康的概念，加之认识到绝经后妇女的增多，研究的倡导者强调需要阐明女性一生的健康状态，包括正常衰老的影响。     

静脉全麻复合骶管阻滞在婴幼儿先天性心脏病介人封堵治疗的研究

目的比较静脉全麻复合单次骶管阻滞麻醉与单纯静脉全麻用于婴幼儿先天性心脏病介入封堵治疗的效果。方法616例婴幼儿先天性心脏病介入封堵治疗患者随机分成两组:骶管阻滞加静脉全麻(I组);另一组用全凭静脉麻醉(II组)。结果全麻药的用量,II组比I组明显增多(P<0.05);I组苏醒时间短,分泌物少,手术后呕吐发生率少(P<0.05)。结论静脉全麻复合小儿单次骶管阻滞麻醉比全凭静脉麻醉用于婴幼儿先天性心脏病介入封堵治疗麻醉费用少,生命体征平稳,麻醉并发症少,值得推广。     

医院管理创新与竞争战略的构建

从医院的现状和未来出发,不断加强医院管理创新的研究,制订出最佳的竞争战略,是医院管理者面临的新课题。医院管理模式只有适应医疗市场的发展变化,全面了解和准确把握医院内部条件和外部环境变化,将潜在的核心能力转化成现实的核心竞争力,医院才能不断发展壮大,才能保持可持续、协调地发展,才能在激烈的市场竞争中取得主动。笔者探讨我院在管理理念、管理结构、管理制度、管理机制等方面的创新,旨在强化和推动医院发展定位、中长期规划、质量建设、数字化建设的构建和实施。     

跟踪国际最新动向提高癫(癎)诊断水平

癫间疒是由多种病因引起的,以脑细胞群异常的超同步化放电为基本病理生理基础的,以突发性、暂时性、发作性症候为主要临床特征的慢性脑功能障碍综合征。癫疒间的临床表现随异常放电的部位和范围而异,最常见的是意识改变或意识丧失和限局性或全身肌肉的强直性或阵挛性抽搐及感觉     

Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry

Recent clinical trials with rapamycin-eluting stents have shown very low restenosis rates.1-4 However, the higher penetration of drug eluting stent (DES) in China is being limited by the high costs of these imported devices, especially when considering multiple stenting.     

可生物降解的聚乳酸羟基乙酸牙周缓释凝胶的研究

目的采用聚乳酸羟基乙酸(PLGA)研制替硝唑牙周缓释凝胶。方法根据聚合物的分子量、浓度、载药量和增塑剂等因素来优选最佳配方。结果聚合物溶液中N-甲基-2-吡咯烷酮(NMP)P、EG400、PLGA(75∶25)的最佳比例为65∶5∶30,5%替硝唑与聚合物溶液均匀混合即得凝胶。凝胶必须在室温下避光保存。结论该凝胶缓释时间长达7d,用于牙周炎的治疗有效。     

细菌受体分析在禽类血清四环素族残留物检测中的应用

目的:以商售 Charm 细菌四环素族受体与四环素族的特异性结合反应为基础,应用其对活体禽类动物血清中四环素族抗生素残留总量进行快速筛选,重点对方法的灵敏度、选择性、基质影响和准确性等进行综合评价。方法:血清经缓冲液稀释,其中的四环素族抗生素残留与~3H 标记的金霉素竞争结合特异性细菌受体。竞争反应温育时间5 min,温度35℃。3300r·min~(-1),5 min 离心分离倾去未结合的游离化合物,复合物沉淀用水溶解,加入闪烁液混匀后放置1 min,进行[~3H]通道的60s 液体闪烁计数。结果:在大于95%的置信水平,血清中四环素、土霉素和金霉素的检测低限分别为80,55,15μg·L~(-1);样本测试表明筛选水平为200μg·L~(-1)时,假阴性率为0,阳性检出结果中假阳性率不超过15%。结论:与色谱法相比,其快速、灵敏、选择性高,可对活体禽类动物血清中四环素族残留物进行高通量筛选。     

患者对预检分诊服务满意度理论框架的扎根理论研究

目的 通过扎根理论研究构建患者视角的预检分诊服务满意度理论框架,为评估和量化患者对预检分诊服务的满意度提供参考。方法 采用目的抽样和理论抽样的方法,选择27例接受过预检分诊服务的患者进行半结构式深度访谈;运用程序化扎根理论的研究方法,采用NVIVO12.0软件辅助对原始数据进行开放式编码、主轴编码及选择性编码,并进行理论饱和度检验。结果 析出患者期望、服务质量、信息供给、人本关怀、持续改进5个主范畴。结论 5个主范畴分别构成预检分诊服务满意度的主体因素、核心因素、关键因素、基本因素和保障因素。该理论框架可为改善预检分诊服务、评估患者满意度提供参考。     

Individual and joint effects of borderline ankle-brachial index and high plasma total homocysteine on all-cause death in hypertensive adults

BACKGROUNDThe cardiovascular hazards of total homocysteine (tHcy) are long known. In addition, despite the acknowledgment on the importance of low ankle-brachial index (ABI) (< 0.9), borderline ABI (0.91-0.99) was once commonly overlooked. This study aims to explore the independent and joint effect of tHcy level and borderline ABI on all-cause death in hypertensive population.METHODSThis study included 10,538 participants from China H-type Hypertension Registry Study. ABI was described into two groups: normal ABI (1.00-1.40) and borderline ABI. tHcy level was also divided into two groups: < 15.02 and ≥ 15.02 μmo/L. Four groups were analyzed, using COX proportional hazard regression model, separately and pairwise to observe the independent and joint effect on all-cause death.RESULTSA total of 126 (1.2%) deaths were observed in the 1.7 years follow-up time. Borderline ABI has a higher predicted risk of death than normal ABI (HR = 1.87, 95%CI: 1.17-3.00) after adjusting for potential covariates. Compare with tHcy level < 15.02 μmo/L (low tHcy), those with tHcy ≥ 15.02 μmo/L (high tHcy) had higher risk to event outcome (HR = 1.99, 95% CI: 1.30-3.05). According to the cumulative hazard curve, group with borderline ABI and high tHcy level has significantly higher altitude and larger increasing rate over follow-up period compare to other groups. Among those with borderline ABI, participants with high tHcy had higher death risk than those with low tHcy, nevertheless, no significant different between borderline and normal ABI among those with low tHcy levels.CONCLUSIONSBorderline ABI and tHcy level both have independent predictive value on all-cause death. The combined group of borderline ABI and high tHcy has highest risk factor of outcomes, which suggested the mutual additive value of borderline ABI and tHcy. More attention should be given to the importance of borderline ABI in hypertensive population, especially with elevated tHcy level.

Homocysteine (Hcy) is a sulfur-containing, non-proteinogenic amino acid synthesized through the transmethylation of amino acid methionine from one-carbon metabolism. Elevated plasma total homocysteine (tHcy) level is associated with endothelial dysfunction, increased blood coagulation, and metabolic disturbance, promoting cardiovascular diseases, stroke, and coronary artery disease.^[1,2] Notably, patients with high Hcy levels and concomitant hypertension were suggested to be at particularly higher risk.^[3] Moreover, increasing studies have explored a positive association between advanced Hcy level with all-cause mortality. According to a recent dose-response meta-analysis, for each 5-μmol/L increment of tHcy levels, the risk for all-cause mortality increased by 33.6%.^[4]The ankle-brachial index (ABI) is an effective, well-established measure that is commonly used in the diagnosis of peripheral artery disease (PAD),^[5] meanwhile was well studied as an important indicator of atherosclerosis and CVD events.^[6] Although ankle-brachial index (ABI) ≤ 0.90 has been recognized as the threshold value for abnormal/low ABI, which was proven to increase the risk of all-cause mortality,^[7] a study from the American Heart Association has suggested ABI between 0.91 and 1.00 should be considered as “borderline area” in terms of cardiovascular risks,^[8] considering of prior probability and sensitivity of ABI calculation. Emerging studies have aimed to explore the predictive value of borderline ABI,^[9-11] however, controversy remains because of limited and inconsistent data. The current study aimed to explore the individual and joint effect of borderline ABI and tHcy on all-cause mortality among hypertensive adults. Although ABI level ≤ 0.90 has been and is going to remain significant in clinical practice, we believe broader concern should be placed on borderline ABI, especially for its value in risk differentiation and identification. To the best of our knowledge, there are no similar previous studies.